Literature DB >> 7991116

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.

Y Stern1, M Albert, J Brandt, D M Jacobs, M X Tang, K Marder, K Bell, M Sano, D P Devanand, F Bylsma.   

Abstract

OBJECTIVE: To examine whether either extrapyramidal signs or psychotic features are associated with more rapid progression of Alzheimer's disease.
BACKGROUND: It has been unclear whether extrapyramidal signs and psychosis are predictors of faster course or are simply late signs.
METHODS: Two hundred thirty-six patients with mild Alzheimer's disease were recruited in three cities and followed semiannually.
RESULTS: Using Cox proportional hazards models that adjusted for age, sex, disease severity, and estimated duration of illness at study entry, the presence of extrapyramidal signs at entry was associated with higher relative risk (RR) of reaching moderate cognitive (RR = 2.35, 95% CI = 1.12 to 4.92) or functional (RR = 2.31, 95% CI = 1.37 to 3.90) severity, nursing home entry (RR = 2.51, 95% CI = 1.32 to 4.76), or death (RR = 3.04, 95% CI = 1.31 to 7.05). Psychosis predicted only the functional end point (RR = 1.85, 95% CI = 1.18 to 2.90). Using regression models, modified Mini-Mental State scores declined 1.30 points (95% CI = 0.16 to 2.44) per 6-month interval, more among patients with than those without extrapyramidal signs; patients with psychosis declined 1.15 (95% CI = 0.52 to 1.77) more mMMS points per interval.
CONCLUSIONS: This study confirms extrapyramidal signs and psychosis as robust predictors of disease end points and rapid progression in Alzheimer's disease.

Entities:  

Mesh:

Year:  1994        PMID: 7991116     DOI: 10.1212/wnl.44.12.2300

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

1.  Predictors of mortality in patients with Alzheimer's disease living in nursing homes.

Authors:  G Gambassi; F Landi; K L Lapane; A Sgadari; V Mor; R Bernabei
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

Review 2.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

3.  Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study.

Authors:  Maria C Norton; Kathleen W Piercy; Peter V Rabins; Robert C Green; John C S Breitner; Truls Ostbye; Christopher Corcoran; Kathleen A Welsh-Bohmer; Constantine G Lyketsos; Joann T Tschanz
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-06-29       Impact factor: 4.077

4.  Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation.

Authors:  Steven P Cercy; Martin J Sadowski; Thomas Wisniewski
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

5.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

6.  The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.

Authors:  J Ellul; N Archer; C M L Foy; M Poppe; H Boothby; H Nicholas; R G Brown; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

7.  Upper and lower extremity motor performance and functional impairment in Alzheimer's disease.

Authors:  Liesi E Hebert; Julia L Bienias; Judith J McCann; Paul A Scherr; Robert S Wilson; Denis A Evans
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-05-19       Impact factor: 2.035

8.  A Case of Biopsy-proven Early-onset Alzheimer's Disease with Hemiparkinsonism.

Authors:  Eun Jung Choi; Hyun Bang; Joo Hyuk Im; Sun Joo Chung; Jae-Hong Lee
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

9.  Predicting progression of Alzheimer's disease.

Authors:  Rachelle S Doody; Valory Pavlik; Paul Massman; Susan Rountree; Eveleen Darby; Wenyaw Chan
Journal:  Alzheimers Res Ther       Date:  2010-02-23       Impact factor: 6.982

10.  Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.

Authors:  Nien-Chen Li; Austin Lee; Rachel A Whitmer; Miia Kivipelto; Elizabeth Lawler; Lewis E Kazis; Benjamin Wolozin
Journal:  BMJ       Date:  2010-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.